Table 2.
The frequency (%) expression of nerve fibers associated with myocytes.
| All participants | Men | Women | ||||
|---|---|---|---|---|---|---|
| Day 0 | Day 4 | Day 0 | Day 4 | Day 0 | Day 4 | |
| SP | 17 (12) | 29 (10)## | 14 (10) | 23 (10) | 20 (14) | 35 (6)#* |
| NR2B | 89 (17) | 88 (9) | 93 (3) | 91 (5) | 85 (24) | 85 (11) |
| NGF | 81 (24) | 84 (15) | 88 (6) | 88 (6) | 74 (33) | 79 (21) |
| SP with NR2B | 16 (12) | 27 (10)## | 13 (9) | 22 (10) | 19 (14) | 32 (7)# |
| SP with NGF | 16 (12) | 25 (9)## | 13 (10) | 21 (9) | 19 (13) | 29 (8) |
| NR2B with NGF | 78 (22) | 79 (15) | 85 (4) | 84 (8) | 72 (31) | 74 (19) |
| ALL | 15 (11) | 24 (8)## | 12 (10) | 21 (9) | 19 (13) | 28 (7) |
The table presents the mean (SD) frequency of nerve fibers expressing markers alone and co-expressions (SP with NR2B, SP with NGF, NR2B with NGF, or All), from all participants, men, women on day 0 and 4. All = SP with NR2B and NGF.
##Significant differences between days in all participants (2-way RM ANOVA; P < 0.05).
#Significant differences between days (Bonferroni; P < 0.05) within men or women.
*Significant differences between men and women (Bonferroni; P < 0.05) within day 0 or day 4.